Investigating how acetaldehyde contributes to oral cancer development
Official title: Dissecting the Role of Acetaldehyde in Oral Carcinogenesis
Run by Masonic Cancer Center, University of Minnesota · NCT05973656 · Data updated 2026-11-12
This study is trying to see how drinking alcohol affects the development of oral cancer in healthy people and those with Fanconi anemia by looking at samples like saliva and urine.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | Masonic Cancer Center, University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | July 8, 2022 |
| Main results expected | January 1, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | July 22, 2026 |
| Trial ID | NCT05973656 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include healthy adults aged 21-45 who consume alcohol occasionally or individuals aged 18-45 with Fanconi anemia who have not consumed alcohol in the last six months.
✕Probably not a fit
Patients with a history of alcohol or drug-related problems or those currently taking medications that affect alcohol metabolism may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This intervention involves healthy volunteers and individuals with Fanconi anemia consuming a single dose of alcohol to study the role of acetaldehyde in oral cancer development. Participants will provide non-invasive biological samples, including saliva, oral cells, and urine, at various time points. Optional blood samples will also be collected for future research. The study aims to understand the biological effects of alcohol consumption on individuals with different genetic backgrounds related to alcohol metabolism.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the mechanisms behind oral cancer development, potentially leading to better prevention strategies.
How similar studies have gone: While the specific approach of this study may be novel, similar studies investigating the effects of alcohol on cancer development have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 21-45 years of age for alcohol drinkers * Occasionally consume alcohol * At least 1 drink per month for healthy volunteers * At least 1 drink in the last 3 months for Fanconi anemia patients * Meets one of the three criteria * Healthy volunteer - ALDH2\*1/1\* homozygotes-not of Eastern Asian decent; * Healthy volunteer - ALDH2\*1/2\* heterozygotes-of Eastern Asian decent and experience flushing when drinking * Individual's with Fanconi anemia (FA). * 18-45 years of age for non-drinkers * Never consume alcohol/not had alcohol in the last 6 months * Healthy volunteers. * Non-smoker (smoked \< 100 cigarettes in a lifetime) Exclusion Criteria: * Pregnant or nursing * Taking any medication or drug that might affect alcohol use and absorption or that might be affected by alcohol consumption * Healthy volunteers who have taken any antibiotics in the last 3 months * Currently consuming more than 21 drinks per week * Have any history of alcohol or drug related problems * Current or former tobacco/nicotine product(s) user * Any regular use of tobacco/nicotine products or marijuana in the last year (cigarettes, e-cigarettes, cigars, pipes, smokeless tobacco) * "Trying" or limited use of any nicotine products or marijuana in the last 1 month * Active infection (influenza, cold, COVID, respiratory / sinus infection) - admission in the study will be delayed pending improved health * Non-FA volunteers who have an unstable medical condition or condition that could be affected by alcohol consumption (insulin-dependent diabetes, ulcers, heart issues) * Experience severe adverse events (nausea, blacking out) when consuming even low doses of alcohol
Where it's running
-
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Study coordinator: Balbo Silvia, PhD
- Email: balbo006@umn.edu
- Phone: 612-624-4240
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia
This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.
-
Understanding congenital bone marrow failure and related disorders through a national network
This project tests whether people with rare inherited bone marrow failure syndromes or related conditions really have the underlying genetic causes, by collecting data and samples across multiple centers.
-
Intraoperative Methadone for Postoperative Pain in Head and Neck Cancer Patients
This trial tests whether giving methadone during surgery, in addition to standard fentanyl, helps control pain after head and neck cancer surgery more effectively than fentanyl alone.
-
Mild heat therapy added to standard treatment for locally advanced head and neck cancer
This early-stage trial tests whether mild hyperthermia can be safely added to standard radiotherapy with or without chemotherapy for locally advanced head and neck cancer.
-
MRI-based noninvasive detection and monitoring of oral lesions in people with Fanconi anemia
This study tests whether MRI and dedicated dental MRI can help detect and track potential oral cancers or precancers in people with Fanconi anemia without surgery or biopsy.
-
Nicotine strength and flavor in oral pouches and alcohol use in young adults
This study tests whether different nicotine strengths and flavors in oral nicotine pouches lead 21–30-year-olds to drink more, drink longer, or have different side effects during and after drinking.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.